News Alerts

19 Jun 2019 | 02:53 PM UTC

Brazil: Authorities announce 14 deaths due to yellow fever as of mid-June

Brazil News Alert

As of mid-June, health officials report at least 81 confirmed cases and 14 related deaths across Brazil since January 1

TIMEFRAME expected from 6/19/2019, 12:00 AM until 6/30/2019, 11:59 PM (America/Sao_Paulo). COUNTRY/REGION Brazil

Event

As of mid-June, at least 81 confirmed cases of yellow fever, and 14 related deaths, have been reported across Brazil since January 1. The most recent death occurred in Santa Catarina. Cases are registered and/or being investigated in São Paulo and Distrito Federal, as well as in the states of Paraná, Santa Catarina,  Pará, Rondônia, Bahia, Ceará, Sergipe, , Goiás, Mato Grosso do Sul, Espírito Santo, Minas Gerais, Rio de Janeiro, and Rio Grande do Sul

The Department of Health has begun an initiative to immunize 100 percent of the population between nine months and 59 years of age.

Context

Symptoms of yellow fever - a mosquito-borne disease - generally appear within three to six days following infection and include fever, chills, muscle and back pain, vomiting, headaches, and, in more serious cases, hemorrhaging and organ failure. The vaccine provides lifelong immunity and should be administered at least ten days prior to travel to an affected area to be fully effective.

Advice

Individuals in or planning travel to the affected areas are advised to stay abreast of local epidemiological developments, consult their doctor regarding vaccination options, and continue to protect themselves against insects due to the presence of mosquito-borne diseases (e.g. by wearing covering clothing, using insect repellent, and sleeping with mosquito screens or nets and/or in air-conditioned rooms).

 

Copyright and Disclaimer
GardaWorld is the owner or licensee of all intellectual property rights in the material presented on this website. All such rights are reserved. The use of this website and its material is subject to the Terms of Use and accordingly you must not use any content from this website for commercial or other analogous purposes without our consent, including but not limited to any deep-linking or framing in order to copy, distribute, display or monitor any portion of the website. If you have any questions or are interested in distributing any content from this website, Contact us for more details.

Related news